Grain Moxibustion Treatment on Insomnia: a Randomized Controlled Trial
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorShanghai Institute of Acupuncture, Moxibustion and Meridian
About this trial
This trial intends to observe the clinical efficacy and safety of grain moxibustion at Baihui(GV20), Xinshu(BL15) and Pishu(BL20) in the treatment of insomnia.
Eligibility criteria
Qualifiers
Meet the diagnostic criteria of insomnia;
TCM syndrome differentiation belongs to deficiency of both heart and spleen;
Male or female participants aged 18-75;
Participants whose PSQI score is 5-15;
Disqualifiers
Participants with mental retardation;
Participants with serious cardiovascular diseases, liver, kidney and hematopoietic system diseases;
Insomnia is caused by nervous system diseases (such as stroke, Parkinson's disease) or mental disorders (including depression or anxiety);
Female participants who is pregnant or lactating;
Trial design
Treatments tested in this trial
- Grain moxibustion
- Sham grain moxibustion
- Standard care
Treatment groups
102 Participants
are divided into 3 treatment groupsSponsors and collaborators
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Lead sponsor
Shanghai University of Traditional Chinese Medicine
Collaborator
Source ClinicalTrials.gov